Operating income decreased 30.4%
Operating income changed -30.4% from the comparable as-filed period.
-$28.9M→-$37.7M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →KMTS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 2749 bp higher
Operating margin changed +2749 basis points from the comparable as-filed period.
-149.08%→-121.59%2 prior comparisons
Revenue increased 59.9%
Revenue changed +59.9% from the comparable as-filed period.
$19.4M→$31.0M2 prior comparisons
Gross margin moved 1081 bp higher
Gross margin changed +1081 basis points from the comparable as-filed period.
45.69%→56.50%2 prior comparisons
Operating cash flow decreased 22.9%
Operating cash flow changed -22.9% from the comparable as-filed period.
-$26.3M→-$32.3M2 prior comparisons
Free-cash-flow proxy decreased 18.0%
Free-cash-flow proxy changed -18.0% from the comparable as-filed period.
-$34.4M→-$40.6M2 prior comparisons
Research & development increased 69.9%
Research & development changed +69.9% from the comparable as-filed period.
$4.0M→$6.8M2 prior comparisons
Cash & equivalents decreased 65.9%
Cash & equivalents changed -65.9% from the comparable as-filed period.
$201.2M→$68.6M2 prior comparisons
Selling, general & administrative increased 43.4%
Selling, general & administrative changed +43.4% from the comparable as-filed period.
$33.7M→$48.4M2 prior comparisons
Gross profit increased 97.7%
Gross profit changed +97.7% from the comparable as-filed period.
$8.9M→$17.5M2 prior comparisons
Capex / revenue moved 1524 bp lower
Capex / revenue changed -1524 basis points from the comparable as-filed period.
42.16%→26.91%2 prior comparisons
Current liabilities increased 49.6%
Current liabilities changed +49.6% from the comparable as-filed period.
$32.3M→$48.3M2 prior comparisons
Stock-based compensation increased 107.8%
Stock-based compensation changed +107.8% from the comparable as-filed period.
$4.6M→$9.5M2 prior comparisons
Total assets increased 30.4%
Total assets changed +30.4% from the comparable as-filed period.
$266.3M→$347.4M2 prior comparisons
Noncurrent long-term debt increased 74.7%
Noncurrent long-term debt changed +74.7% from the comparable as-filed period.
$41.5M→$72.5M2 prior comparisons
Cost of revenue increased 28.1%
Cost of revenue changed +28.1% from the comparable as-filed period.
$10.5M→$13.5M2 prior comparisons
SBC / revenue moved 709 bp higher
SBC / revenue changed +709 basis points from the comparable as-filed period.
23.64%→30.73%2 prior comparisons
Operating cash-flow margin moved 3136 bp higher
Operating cash-flow margin changed +3136 basis points from the comparable as-filed period.
-135.64%→-104.27%2 prior comparisons
Free-cash-flow margin moved 4660 bp higher
Free-cash-flow margin changed +4660 basis points from the comparable as-filed period.
-177.79%→-131.19%2 prior comparisons
Shares outstanding increased 15.8%
Shares outstanding changed +15.8% from the comparable as-filed period.
51,449,053→59,561,7952 prior comparisons
Working capital / assets moved 1952 bp lower
Working capital / assets changed -1952 basis points from the comparable as-filed period.
70.76%→51.25%2 prior comparisons
Current ratio decreased 31.5%
Current ratio changed -31.5% from the comparable as-filed period.
6.84→4.692 prior comparisons
R&D / revenue moved 129 bp higher
R&D / revenue changed +129 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
20.65%→21.94%2 prior comparisons
Working capital decreased 5.5%
Working capital changed -5.5% from the comparable as-filed period.
$188.4M→$178.0M2 prior comparisons
Current assets increased 2.5%
Current assets changed +2.5% from the comparable as-filed period.
$220.7M→$226.3M2 prior comparisons
Capital expenditure increased 2.1%
Capital expenditure changed +2.1% from the comparable as-filed period.
$8.2M→$8.3M2 prior comparisons
Shares outstanding increased 13.7%
Shares outstanding changed +13.7% from the comparable as-filed period.
51,348,656→58,373,3530 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.